Assessment and optimization of Theileria parva sporozoite full-length p67 antigen expression in mammalian cells

Delivery of various forms of recombinant Theileria parva sporozoite antigen (p67) has been shown to elicit antibody responses in cattle capable of providing protection against East Coast fever, the clinical disease caused by T. parva. Previous formulations of full-length and shorter recombinant versions of p67 derived from bacteria, insect, and mammalian cell systems are expressed in non-native and highly unstable forms. The stable expression of full-length recombinant p67 in mammalian cells has never been described and has remained especially elusive. In this study, p67 was expressed in human-derived cells as a full-length, membrane-linked protein and as a secreted form by omission of the putative transmembrane domain. The recombinant protein expressed in this system yielded primarily two products based on Western immunoblot analysis, including one at the expected size of 67 kDa, and one with a higher than expected molecular weight. Through treatment with PNGase F, our data indicate that the larger product of this mammalian cell-expressed recombinant p67 cannot be attributed to glycosylation. By increasing the denaturing conditions, we determined that the larger sized mammalian cell-expressed recombinant p67 product is likely a dimeric aggregate of the protein. Both forms of this recombinant p67 reacted with a monoclonal antibody to the p67 molecule, which reacts with the native sporozoite. Additionally, through this work we developed multiple mammalian cell lines, including both human and bovine-derived cell lines, transduced by a lentiviral vector, that are constitutively able to express a stable, secreted form of p67 for use in immunization, diagnostics, or in vitro assays. The recombinant p67 developed in this system is immunogenic in goats and cattle based on ELISA and flow cytometric analysis. The development of a mammalian cell system that expresses full-length p67 in a stable form as described here is expected to optimize p67-based immunization.Fil: Tebaldi, Giulia. Università di Parma; ItaliaFil: Williams, Laura B.. Washington State University. Animal Disease Research Unit, Agricultural Research Service. United States Department of Agriculture and Department of Veterinary Microbiology & Pathology; Estados UnidosFil: Verna, Andrea Elizabeth. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto Nacional de Tecnología Agropecuaria. Centro Regional Buenos Aires Sur. Estación Experimental Agropecuaria Balcarce. Laboratorio de Biotecnología de la Reproduccion; Argentina. Università di Parma; ItaliaFil: Macchi, Francesca. Universita di Parma. Dipartimento Di Scienze Medico Veterinarie; ItaliaFil: Franceschi, Valentina. Universita di Parma. Dipartimento Di Scienze Medico Veterinarie; ItaliaFil: Fry, Lindsay M.. Washington State University. Animal Disease Research Unit, Agricultural Research Service. United States Department of Agriculture and Department of Veterinary Microbiology & Pathology; Estados UnidosFil: Knowles, Donald P.. Washington State University. Animal Disease Research Unit, Agricultural Research Service. United States Department of Agriculture and Department of Veterinary Microbiology & Pathology; Estados UnidosFil: Donofrio, Gaetano. Washington State University College of Veterinary Medicine. Paul G. Allen School for Global Animal Health; Estados Unido